24 02, 2017 Caterina De Luca et al., KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test. CytoJournal Diatech Pharmacogenetics2017-08-25T09:41:37+02:00 Read More
22 02, 2017 Alessia Nottegar et al., Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Experimental and Molecular Pathology Diatech Pharmacogenetics2017-02-22T15:47:47+01:00 Read More
31 01, 2017 Daniela Furlan et al., Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis. British Journal of Cancer Diatech Pharmacogenetics2017-08-08T12:54:16+02:00 Read More
23 01, 2017 Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report Diatech Pharmacogenetics2017-11-02T13:08:34+01:00 Read More
23 01, 2017 Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Oncology Letters Diatech Pharmacogenetics2017-01-23T09:45:46+01:00 Read More
21 01, 2017 Egesta Lopci et al., Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European Journal of Nuclear Medicine and Molecular Imaging Diatech Pharmacogenetics2017-01-21T16:48:36+01:00 Read More
1 01, 2017 Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report. International Journal of Surgical Pathology Diatech Pharmacogenetics2017-01-01T16:57:16+01:00 Read More
23 12, 2016 Luca Reggiani Bonetti et al., Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer Diatech Pharmacogenetics2017-11-02T13:28:53+01:00 Read More
13 12, 2016 Chiara Cremolini et al., Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer Diatech Pharmacogenetics2017-08-03T17:23:47+02:00 Read More
8 12, 2016 Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications Diatech Pharmacogenetics2016-12-08T17:27:27+01:00 Read More
